Senior insider sale
TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$814.6K
257.05K shares
What this filing means
NAGENDRAN SUKUMAR plans to sell 257.05K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $814.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/10/2025ACC: 0001974158-25-000058
Director
Since Sep 2020
257.05K
Shares to sell
$814.6K
Approx. market value
200K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Vested RSU Award
N/A
1/2/2024
158.85KVested Stock Option Grant
N/A
5/31/2023
37.11KVested Stock Option Grant
N/A
5/31/2023
4.04KTotal acquired200K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/2/2024 | Vested RSU Award N/A | 158.85K | — |
5/31/2023 | Vested Stock Option Grant N/A | 37.11K | — |
5/31/2023 | Vested Stock Option Grant N/A | 4.04K | — |
| Total | 200K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
57.05K
Market value
$162.6K
8/21/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
200K
Market value
$652.0K
9/10/2025
Total
Units
257.05K
Value
$814.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/21/2025 | 57.05K | $162.6K | — | Completed |
| Planned — Approximate Date | ||||
9/10/2025 | 200K | $652.0K | Nasdaq | Planned |
| Total | 257.05K | $814.6K | ||